Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Patent
1991-06-28
1992-04-07
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
514824, A61K 31075
Patent
active
051029154
ABSTRACT:
The present invention relates to a group of compounds which are novel squalene derivatives containing the cyclopropyloxy functionality and which act to inhibit the synthesis of cholesterol in mammals and in fungi.
REFERENCES:
patent: 2330979 (1943-10-01), Krantz et al.
patent: 4891367 (1990-01-01), Angelastro et al.
Sen et al., J. Am. Chem. Soc. 111,1508-1510 (1989).
Taylor et al., J. Biol. Chem. 261(320, 15039-44 (1986).
Cattel et al., Lipids 21(1), 31-38 (1986).
Angelastro Michael R.
Bey Philippe
Peet Norton P.
Jordan Kimberly R.
Merrell Dow Pharmaceuticals Inc.
Sayles Michael J.
Waddell Frederick E.
LandOfFree
Cyclopropyl squalene derivatives and their use as inhibitors of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopropyl squalene derivatives and their use as inhibitors of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl squalene derivatives and their use as inhibitors of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895762